HCW Biologics (HCWB) Competitors $0.39 0.00 (-0.26%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.39 0.00 (-0.77%) As of 02/21/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCWB vs. OPTN, RVPH, OTLK, PDSB, VNRX, ALXO, IMRX, ACHL, FGEN, and IMMXShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include OptiNose (OPTN), Reviva Pharmaceuticals (RVPH), Outlook Therapeutics (OTLK), PDS Biotechnology (PDSB), VolitionRx (VNRX), ALX Oncology (ALXO), Immuneering (IMRX), Achilles Therapeutics (ACHL), FibroGen (FGEN), and Immix Biopharma (IMMX). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. OptiNose Reviva Pharmaceuticals Outlook Therapeutics PDS Biotechnology VolitionRx ALX Oncology Immuneering Achilles Therapeutics FibroGen Immix Biopharma OptiNose (NASDAQ:OPTN) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Which has better earnings and valuation, OPTN or HCWB? HCW Biologics has lower revenue, but higher earnings than OptiNose. OptiNose is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOptiNose$70.99M0.82-$35.48M-$4.20-1.37HCW Biologics$2.84M6.12-$24.99M-$1.00-0.39 Does the MarketBeat Community prefer OPTN or HCWB? OptiNose received 243 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 63.68% of users gave OptiNose an outperform vote. CompanyUnderperformOutperformOptiNoseOutperform Votes24963.68% Underperform Votes14236.32% HCW BiologicsOutperform Votes6100.00% Underperform VotesNo Votes Do institutionals and insiders believe in OPTN or HCWB? 85.6% of OptiNose shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 2.3% of OptiNose shares are held by insiders. Comparatively, 49.9% of HCW Biologics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, OPTN or HCWB? OptiNose has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Is OPTN or HCWB more profitable? OptiNose has a net margin of -41.16% compared to HCW Biologics' net margin of -1,067.82%. OptiNose's return on equity of 0.00% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets OptiNose-41.16% N/A -27.42% HCW Biologics -1,067.82%-2,516.84%-132.95% Do analysts recommend OPTN or HCWB? OptiNose currently has a consensus target price of $16.67, indicating a potential upside of 188.85%. Given OptiNose's stronger consensus rating and higher probable upside, equities research analysts clearly believe OptiNose is more favorable than HCW Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OptiNose 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to OPTN or HCWB? In the previous week, OptiNose and OptiNose both had 1 articles in the media. OptiNose's average media sentiment score of 1.94 beat HCW Biologics' score of 0.00 indicating that OptiNose is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptiNose 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive HCW Biologics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryOptiNose beats HCW Biologics on 10 of the 17 factors compared between the two stocks. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.37M$7.04B$5.77B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E Ratio-0.396.1326.4618.82Price / Sales6.12309.83453.2580.30Price / CashN/A67.8344.0437.47Price / Book1.056.747.634.64Net Income-$24.99M$138.11M$3.18B$245.69M7 Day Performance-2.52%-2.43%-1.91%-2.66%1 Month Performance14.71%-1.91%-0.19%-2.15%1 Year Performance-66.95%-5.03%16.70%12.90% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics0.2584 of 5 stars$0.39-0.3%N/A-65.5%$17.37M$2.84M-0.3940OPTNOptiNose4.2591 of 5 stars$6.00+6.8%$16.67+177.8%-71.3%$60.36M$70.99M-1.43190Positive NewsRVPHReviva Pharmaceuticals3.4487 of 5 stars$1.80flat$11.40+533.3%-63.1%$60.19MN/A-1.625OTLKOutlook Therapeutics2.0784 of 5 stars$1.87+1.6%$27.40+1,365.2%-81.3%$59.80MN/A-0.2120Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePDSBPDS Biotechnology1.0401 of 5 stars$1.56+4.0%$11.67+647.9%-74.7%$58.36MN/A-1.3420News CoverageGap UpVNRXVolitionRx1.863 of 5 stars$0.63+9.1%$3.75+498.1%-43.1%$58.10M$1.29M-1.7480ALXOALX Oncology3.4091 of 5 stars$1.10+1.9%$3.05+177.3%-93.0%$58.01MN/A-0.3740IMRXImmuneering3.0181 of 5 stars$1.86flat$12.20+555.9%-72.6%$57.75M$320,000.00-0.9460ACHLAchilles Therapeutics2.6731 of 5 stars$1.38-0.7%$4.00+189.9%+12.2%$56.72MN/A-0.84250High Trading VolumeFGENFibroGen4.5079 of 5 stars$0.55+6.5%N/A-58.8%$55.88M$147.75M-0.45570Upcoming EarningsAnalyst ForecastShort Interest ↓News CoverageGap DownIMMXImmix Biopharma2.6059 of 5 stars$1.98-0.5%$7.00+253.5%-41.1%$54.47MN/A-2.339 Related Companies and Tools Related Companies OptiNose Competitors Reviva Pharmaceuticals Competitors Outlook Therapeutics Competitors PDS Biotechnology Competitors VolitionRx Competitors ALX Oncology Competitors Immuneering Competitors Achilles Therapeutics Competitors FibroGen Competitors Immix Biopharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCWB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
